{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:09:31Z","timestamp":1777572571712,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It has been suggested recently, based on pharmacokinetic-pharmacodynamic modelling exercises, that twice daily dosing of artemisinins increases malaria parasite killing and so could \u201cdramatically enhance and restore drug effectiveness\u201d in artemisinin resistant <jats:italic>P. falciparum<\/jats:italic> malaria infections. It was recommended that split dosing should be incorporated into all artemisinin combination regimen designs. To explain why parasite clearance rates were not faster with split dose regimens it was concluded that splenic malaria parasite clearance capacity was readily exceeded, resulting in the accumulation of dead parasites in the circulation, that parasite clearance was therefore an unreliable measure of drug efficacy, and instead that human immunity is the primary determinant of clearance rates. To test these various hypotheses we performed a logistic meta-regression analysis of cure rates from all falciparum malaria treatment trials (n\u2009=\u200940) with monotherapy arms containing artemisinin or a derivative (76 arms). There was no evidence that split dosing enhanced cure rates.<\/jats:p>","DOI":"10.1038\/s41598-017-12483-4","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T14:36:47Z","timestamp":1505486207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Split dosing of artemisinins does not improve antimalarial therapeutic efficacy"],"prefix":"10.1038","volume":"7","author":[{"given":"N. J.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"12483_CR1","unstructured":"Qinghaosu Antimalarial Coordinating Research Group. Antimalaria studies on Qinghaosu. Chinese Medical Journal \n                           92, 811\u2013816 (1979)."},{"key":"12483_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(82)90268-9","volume":"2","author":"JB Jiang","year":"1982","unstructured":"Jiang, J. B., Li, G. Q., Guo, X. B., Kong, Y. C. & Arnold, K. Antimalarial activity of mefloquine and qinghaosu. Lancet \n                           2, 285\u2013288 (1982).","journal-title":"Lancet"},{"key":"12483_CR3","first-page":"125","volume":"2","author":"GQ Li","year":"1982","unstructured":"Li, G. Q. et al. Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. Journal of Traditional Chinese Medicine=Chung i tsa chih ying wen pan \n                           2, 125\u2013130 (1982).","journal-title":"Journal of Traditional Chinese Medicine=Chung i tsa chih ying wen pan"},{"key":"12483_CR4","first-page":"539","volume":"22","author":"D Bunnag","year":"1991","unstructured":"Bunnag, D., Viravan, C., Looareesuwan, S., Karbwang, J. & Harinasuta, T. Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. The Southeast Asian Journal of Tropical Medicine and Public Health \n                           22, 539\u2013543 (1991).","journal-title":"The Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"12483_CR5","first-page":"380","volume":"22","author":"D Bunnag","year":"1991","unstructured":"Bunnag, D., Viravan, C., Looareesuwan, S., Karbwang, J. & Harinasuta, T. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. The Southeast Asian Journal of Tropical Medicine and Public Health \n                           22, 380\u2013385 (1991).","journal-title":"The Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"12483_CR6","first-page":"534","volume":"22","author":"D Bunnag","year":"1991","unstructured":"Bunnag, D., Viravan, C., Looareesuwan, S., Karbwang, J. & Harinasuta, T. Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria. The Southeast Asian Journal of Tropical Medicine and Public Health \n                           22, 534\u2013538 (1991).","journal-title":"The Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"12483_CR7","first-page":"762","volume":"23","author":"D Bunnag","year":"1992","unstructured":"Bunnag, D., Karbwang, J. & Harinasuta, T. Artemether in the treatment of multiple drug resistant falciparum malaria. The Southeast Asian Journal of Tropical Medicine and Public Health \n                           23, 762\u2013767 (1992).","journal-title":"The Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"Suppl 1","key":"12483_CR8","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/0035-9203(94)90462-6","volume":"88","author":"S Looareesuwan","year":"1994","unstructured":"Looareesuwan, S. Overview of clinical studies on artemisinin derivatives in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene \n                           88(Suppl 1), S9\u201311 (1994).","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"Suppl 1","key":"12483_CR9","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/0035-9203(94)90460-X","volume":"88","author":"GQ Li","year":"1994","unstructured":"Li, G. Q., Guo, X. B., Fu, L. C., Jian, H. X. & Wang, X. H. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Transactions of the Royal Society of Tropical Medicine and Hygiene \n                           88(Suppl 1), S5\u20136 (1994).","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"Suppl 1","key":"12483_CR10","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/0035-9203(94)90461-8","volume":"88","author":"TT Hien","year":"1994","unstructured":"Hien, T. T. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam. Transactions of the Royal Society of Tropical Medicine and Hygiene \n                           88(Suppl 1), S7\u20138 (1994).","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"12483_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/infdis\/170.4.971","volume":"170","author":"F Nosten","year":"1994","unstructured":"Nosten, F. et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. The Journal of Infectious Diseases \n                           170, 971\u2013977 (1994).","journal-title":"The Journal of Infectious Diseases"},{"key":"12483_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0035-9203(94)90303-4","volume":"88","author":"C Luxemburger","year":"1994","unstructured":"Luxemburger, C. et al. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene \n                           88, 213\u2013217 (1994).","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"12483_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000256","author":"HM McIntosh","year":"2000","unstructured":"McIntosh, H. M. & Olliaro, P. Artemisinin derivatives for treating uncomplicated malaria. The Cochrane database of systematic reviews, CD000256. https:\/\/doi.org\/10.1002\/14651858.CD000256 (2000).","journal-title":"The Cochrane database of systematic reviews, CD000256"},{"key":"12483_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1073\/pnas.1006113108","volume":"108","author":"S Saralamba","year":"2011","unstructured":"Saralamba, S. et al. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America \n                           108, 397\u2013402, https:\/\/doi.org\/10.1073\/pnas.1006113108 (2011).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"12483_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002132","volume":"13","author":"C Dogovski","year":"2015","unstructured":"Dogovski, C. et al. Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance. PLoS Biology \n                           13, e1002132, https:\/\/doi.org\/10.1371\/journal.pbio.1002132 (2015).","journal-title":"PLoS Biology"},{"key":"12483_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003151","volume":"9","author":"K Kay","year":"2013","unstructured":"Kay, K. & Hastings, I. M. Improving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugs. PLoS Computational Biology \n                           9, e1003151, https:\/\/doi.org\/10.1371\/journal.pcbi.1003151 (2013).","journal-title":"PLoS Computational Biology"},{"key":"12483_CR17","doi-asserted-by":"publisher","first-page":"6428","DOI":"10.1128\/AAC.00481-15","volume":"59","author":"IM Hastings","year":"2015","unstructured":"Hastings, I. M., Kay, K. & Hodel, E. M. How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance? Antimicrobial Agents and Chemotherapy \n                           59, 6428\u20136436, https:\/\/doi.org\/10.1128\/AAC.00481-15 (2015).","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"12483_CR18","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1128\/AAC.00482-15","volume":"59","author":"K Kay","year":"2015","unstructured":"Kay, K., Hodel, E. M. & Hastings, I. M. Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness. Antimicrobial Agents and Chemotherapy \n                           59, 6419\u20136427, https:\/\/doi.org\/10.1128\/AAC.00482-15 (2015).","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"12483_CR19","doi-asserted-by":"publisher","unstructured":"WWARN Parasite Clearance Study Group et al. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis. Malaria Journal \n                           14, 359, doi:https:\/\/doi.org\/10.1186\/s12936-015-0874-1 (2015).","DOI":"10.1186\/s12936-015-0874-1"},{"key":"12483_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-97","volume":"9","author":"NH Phu","year":"2010","unstructured":"Phu, N. H. et al. Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malaria Journal \n                           9, 97, https:\/\/doi.org\/10.1186\/1475-2875-9-97 (2010).","journal-title":"Malaria Journal"},{"key":"12483_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1473-3099(15)00320-5","volume":"16","author":"AP Phyo","year":"2016","unstructured":"Phyo, A. P. et al. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. The Lancet Infectious Diseases \n                           16, 61\u201369, https:\/\/doi.org\/10.1016\/S1473-3099(15)00320-5 (2016).","journal-title":"The Lancet Infectious Diseases"},{"key":"12483_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1365-2125.2005.02508.x","volume":"60","author":"T Gordi","year":"2005","unstructured":"Gordi, T., Xie, R. & Jusko, W. J. Semi-mechanistic pharmacokinetic\/pharmacodynamic modelling of the antimalarial effect of artemisinin. British Journal of Clinical Pharmacology \n                           60, 594\u2013604, https:\/\/doi.org\/10.1111\/j.1365-2125.2005.02508.x (2005).","journal-title":"British Journal of Clinical Pharmacology"},{"key":"12483_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep32762","volume":"6","author":"IM Hastings","year":"2016","unstructured":"Hastings, I. M., Hodel, E. M. & Kay, K. Quantifying the pharmacology of antimalarial drug combination therapy. Scientific Reports \n                           6, 32762, https:\/\/doi.org\/10.1038\/srep32762 (2016).","journal-title":"Scientific Reports"},{"key":"12483_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/650301","volume":"201","author":"K Stepniewska","year":"2010","unstructured":"Stepniewska, K. et al. In vivo parasitological measures of artemisinin susceptibility. The Journal of Infectious Diseases \n                           201, 570\u2013579, https:\/\/doi.org\/10.1086\/650301 (2010).","journal-title":"The Journal of Infectious Diseases"},{"key":"12483_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057689","volume":"8","author":"MP Kyaw","year":"2013","unstructured":"Kyaw, M. P. et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PloS One \n                           8, e57689, https:\/\/doi.org\/10.1371\/journal.pone.0057689 (2013).","journal-title":"PloS One"},{"key":"12483_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. The New England Journal of Medicine \n                           361, 455\u2013467, https:\/\/doi.org\/10.1056\/NEJMoa0808859 (2009).","journal-title":"The New England Journal of Medicine"},{"key":"12483_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley, E. A. et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. The New England Journal of Medicine \n                           371, 411\u2013423, https:\/\/doi.org\/10.1056\/NEJMoa1314981 (2014).","journal-title":"The New England Journal of Medicine"},{"key":"12483_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/infdis\/jit165","volume":"208","author":"SC Nkhoma","year":"2013","unstructured":"Nkhoma, S. C. et al. Genetic evaluation of the performance of malaria parasite clearance rate metrics. The Journal of Infectious Diseases \n                           208, 346\u2013350, https:\/\/doi.org\/10.1093\/infdis\/jit165 (2013).","journal-title":"The Journal of Infectious Diseases"},{"key":"12483_CR29","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.1615875114","volume":"114","author":"R Ataide","year":"2017","unstructured":"Ataide, R. et al. Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort. Proceedings of the National Academy of Sciences of the United States of America \n                           114, 3515\u20133520, https:\/\/doi.org\/10.1073\/pnas.1615875114 (2017).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"12483_CR30","doi-asserted-by":"publisher","unstructured":"WWARN Artemisinin based Combination Therapy Africa Baseline Study Group et al. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC medicine \n                           13, 212, doi:https:\/\/doi.org\/10.1186\/s12916-015-0445-x (2015).","DOI":"10.1186\/s12916-015-0445-x"},{"key":"12483_CR31","unstructured":"WorldWide Antimalarial Resistance Network. WWARN Clinical Trials Publication library., http:\/\/www.wwarn.org\/tools-resources\/literature-reviews\/wwarn-clinical-trials-publication-library (2017)."},{"key":"12483_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-3156.2006.01785.x","volume":"12","author":"EA Ashley","year":"2007","unstructured":"Ashley, E. A. et al. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria. Tropical Medicine & International Health: TM & IH \n                           12, 201\u2013208, https:\/\/doi.org\/10.1111\/j.1365-3156.2006.01785.x (2007).","journal-title":"Tropical Medicine & International Health: TM & IH"},{"key":"12483_CR33","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1086\/430309","volume":"40","author":"M Ramharter","year":"2005","unstructured":"Ramharter, M. et al. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clinical Infectious Diseases \n                           40, 1777\u20131784, https:\/\/doi.org\/10.1086\/430309 (2005).","journal-title":"Clinical Infectious Diseases"},{"key":"12483_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1086\/432011","volume":"41","author":"EA Ashley","year":"2005","unstructured":"Ashley, E. A. et al. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clinical Infectious Diseases \n                           41, 425\u2013432, https:\/\/doi.org\/10.1086\/432011 (2005).","journal-title":"Clinical Infectious Diseases"},{"key":"12483_CR35","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1086\/657120","volume":"51","author":"H Noedl","year":"2010","unstructured":"Noedl, H. et al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clinical Infectious Diseases \n                           51, e82\u201389, https:\/\/doi.org\/10.1086\/657120 (2010).","journal-title":"Clinical Infectious Diseases"},{"key":"12483_CR36","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/cid\/cis958","volume":"56","author":"D Das","year":"2013","unstructured":"Das, D. et al. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria. Clinical Infectious Diseases \n                           56, e48\u201358, https:\/\/doi.org\/10.1093\/cid\/cis958 (2013).","journal-title":"Clinical Infectious Diseases"},{"key":"12483_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001938","volume":"13","author":"PG Kremsner","year":"2016","unstructured":"Kremsner, P. G. et al. Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial. PLoS Medicine \n                           13, e1001938, https:\/\/doi.org\/10.1371\/journal.pmed.1001938 (2016).","journal-title":"PLoS Medicine"},{"key":"12483_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4269\/ajtmh.1997.56.613","volume":"56","author":"S Looareesuwan","year":"1997","unstructured":"Looareesuwan, S. et al. Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria. The American Journal of Tropical Medicine and Hygiene \n                           56, 613\u2013617 (1997).","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"12483_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1731-1","volume":"16","author":"NJ White","year":"2017","unstructured":"White, N. J. Malaria parasite clearance. Malaria Journal \n                           16, 88, https:\/\/doi.org\/10.1186\/s12936-017-1731-1 (2017).","journal-title":"Malaria Journal"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12483-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:18:57Z","timestamp":1671794337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12483-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12483-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]},"assertion":[{"value":"29 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12132"}}